InvestorsHub Logo

rosemountbomber

08/29/20 9:32 AM

#293514 RE: Jasbg #293512

But disappointing that he has seen NO scripts for V. Shouldn’t need Evaporate data to have V prescribed. R-I like data for CVD has not been seen for over 30 years.

And V has been incorporated into medical society guidelines over a year ago. What have the reps been doing in his area?

couldbebetter

08/29/20 9:38 AM

#293516 RE: Jasbg #293512

jasbg, There will never be optimal usage of Vascepa unless or until
AMRN is acquired by BP. If THAT never happens, then Vascepa, as a
promising Cardiovascular drug approved in the US, will be "LAID TO
WASTE!"